In the past two years, there has been an increasing number of lawsuits against manufacturers of baby formula. These lawsuits are alleging that baby formula products from manufacturers Abbott Laboratories and Mead Johnson led to significant health complications in infants. Namely, these lawsuits allege that their infants developed necrotizing enterocolitis (NEC), which is a rare intestinal disorder.
November 2024 Update
The multidistrict litigation (MDL 3026) involving necrotizing enterocolitis (NEC) cases linked to baby formula has seen 598 lawsuits pending before U.S. District Judge Rebecca Pallmeyer in Illinois. While no settlements or jury verdicts have been reached within the MDL thus far, recent state court rulings in Illinois and Missouri awarded plaintiffs substantial damages, including a $60 million verdict in March and a $496 million verdict in July. A trial schedule has been proposed, with the first MDL bellwether trial set to commence on May 5, 2025, as both parties prepare for the upcoming legal battles and continue to negotiate potential settlements.
You May Be Eligible for NEC Lawsuit
These lawsuits have come about partly because numerous studies suggest that giving a premature baby formula increases their risk of developing NEC. The lawsuits are alleging that the manufacturers of these products failed to adequately warn customers of the risks and instead marketed the products as safe.
If your child suffered from NEC after taking toxic baby formula, you may be eligible for a lawsuit. Our team is currently reviewing NEC baby formula cases and wants to represent families who have suffered as a result of these baby formula products. Call our legal advisors today in all 50 states at 855-625-7778 or complete the form if you’d like a call back.
Toxic Baby Formula Timeline:
September 2024
- 30th – Lawyers in the NEC MDL are expected to submit a joint proposal for trial dates by Friday. This marks a significant step forward as the litigation prepares for upcoming trials.
- 23rd – A National Institutes of Health-funded study published in the Journal of the American Medical Association found that extremely preterm infants fed donor human milk had half the incidence of NEC compared to those fed formula (4.2% vs. 9%). This study provides strong evidence that supports plaintiffs’ claims in the NEC litigation, as it highlights the increased risk of NEC associated with formula feeding in vulnerable preterm infants.
- 9th – Tort reform lobbyists criticized two large NEC baby formula verdicts, one awarding $95 million in Missouri and another $60 million in Illinois. Despite labeling the scientific basis as “junk science,” the article fails to provide evidence refuting the claims, with some concerns focusing on potential risks to formula availability for preterm infants. However, plaintiffs argue that manufacturers simply need to provide adequate warnings to doctors and parents about the NEC risks for informed decision-making.
- 3rd – Thirty-three new cases were added to the NEC MDL in August, bringing the total number of pending cases to 571. This steady growth reflects ongoing claims against formula manufacturers for their alleged role in causing NEC in preterm infants.
August 2024
- 26th – The wrongful death case Mar v. Abbott Laboratories was selected as the first bellwether trial in the NEC litigation. The case involves the death of a premature baby who developed NEC after being fed Similac Special Care 24. The lawsuit claims that the cow’s milk-based formula caused the baby’s fatal condition, and the mother is seeking justice for her daughter’s wrongful death.
- 25th – The parties in the NEC MDL agreed on the order of the first four bellwether trials, starting with Mar v. Abbott Laboratories. This agreement was reached pending dispositive motions and allows the parties to seek summary judgment. A request has also been made to hold the upcoming August 29, 2024, Status Conference remotely.
- 17th – Philadelphia is expected to become a key venue for NEC baby formula lawsuits, following a recent big verdict in St. Louis. Lawyers are employing new strategies in Philadelphia, including suing hospitals alongside manufacturers like Mead Johnson and Abbott for failing to warn about the risks of cow’s milk-based formulas in premature infants.
- 9th – Mead Johnson filed a notice to remove an NEC lawsuit to the MDL in Illinois. The lawsuit was brought by a Virginia resident whose premature infant daughter developed NEC and died after consuming Mead Johnson’s formula. Mead Johnson argues that Abbott Laboratories was fraudulently joined in the case to prevent its removal to federal court.
July 2024
- A Missouri jury awarded $495 million in damages ($95 million in compensatory and $400 million in punitive damages) to a girl’s family after consuming specialized formula made by Abbott Labs for premature babies.
May 2024
- Over forty new cases were added to the NEC preterm infant formula MDL. The case volume continues to grow each month, reaching almost 500.
March 2024
- An Illinois jury awarded $60 million to parents of an infant who died from NEC after consuming Enfamil, a Mead Johnson baby formula.
December 2023
- Four bellwether cases had been selected and attorneys expect cases to start in first half of 2024.
January 2023
- The Justice Department’s consumer protection branch begins investigating the conduct at the Sturgis plant that led to its shutdown.
August 2022
- Abbott restarts Similac infant formula production at the Sturgis facility and estimates a six-week period before the product begins shipping to retail locations.
July 2022
- Abbott resumes production, starting with EleCare and some metabolic formulas.
June 2022
- Abbott restarts production at the Sturgis plant but then pauses production due to severe weather.
May 2022
- Abbott warns of a delay in getting new products on store shelves. Retailers, including Target, CVS, and Walgreens, impose purchasing limitations on baby formula due to the worsening nationwide shortage.
April 2022
- Abbott submits a response and corrective action plan to the FDA.
- Abbott announces that none of the distributed formula tested positive for Cronobacter sakazakii or salmonella.
March 2022
- FDA inspection reveals that Abbott didn’t maintain clean surfaces used in producing and handling the powdered formula and finds a history of contamination with cronobacter bacteria.
February 2022
- Abbott initiates a recall of certain Similac, Alimentum, and EleCare powdered infant formulas manufactured at the Sturgis plant and ceases operations at the facility. The FDA issues a warning about Abbott’s recalled formula following four bacterial infections among infants, two of whom died.
January 31, 2022
- FDA sends inspectors to the Sturgis facility, beginning their investigation.
December 2021
- An interview with the whistleblower employee takes place.
October 2021
- FDA receives a whistleblower complaint about numerous safety violations at the Michigan plant, including claims that employees falsified records and failed to properly test the formula before releasing it.
Toxic Baby Formula Lawsuit Updates
- Historic $6 Billion Lawsuit Targets Major Baby Formula Manufacturers (10/31/2024)
- NEC Lawsuits Shake Infant Formula Industry: A $60 Million Verdict and Its Ripple Effects (8/12/2024)
- Abbott Faces $495 Million Verdict in Landmark NEC Lawsuit Settlement (7/29/2024)
- Landmark $60 Million Verdict in Baby Formula Lawsuit: What Families Need to Know (5/17/2024)
- Minnesota Mom Sues Baby Formula Makers, Claiming Hidden NEC Risk in Premature Infants (5/14/2024)
- Navigating the Complexities of Baby NEC Multidistrict Litigation (8/19/2023)
Is there a toxic baby formula lawsuit?
Yes, there are multiple lawsuits against manufacturers of baby formula, claiming that these companies should have warned that their products were unsafe. The plaintiffs are suing for extensive financial losses and emotional distress, due to their baby suffering injuries or dying. These lawsuits started to appear in 2021 when several plaintiffs alleged that the manufacturers of baby formula did not properly disclose the dangers of using their products. After more cases began to appear, Abbott Laboratories, the makers of Similac baby formula, filed to consolidate all of the cases into one court in January 2022.
Shortly after that, in February of 2022, Mead Johnson, the makers of Enfamil, filed a statement with the courts saying that they agreed with consolidation. Then, on April 8, 2022, the Multidistrict Litigation Panel created a new multidistrict litigation (MDL) under Judge Rebecca Pallmeyer in the U.S. District Court of Illinois. By the beginning of June 2022, there were more than 75 lawsuits consolidated into this MDL.
In August 2022, attorneys for both sides in the MDL submitted a plan for selecting bellwether cases. Bellwether cases are a few choice cases within the MDL. These cases go to trial, where both the plaintiffs and the defendants can learn more about how juries will react to the evidence. Parties on both sides can then use this information to determine how to best proceed with the remaining cases. The bellwether cases have yet to begin trial, but the MDL continues to get more cases. There are now roughly 180 cases inside the MDL, a significant increase over one year prior.
The current lawsuits name a wide range of baby formula products from the brand names Similac and Enfamil. These products include:
- Similac Special Care
- Similac Human Milk Fortifier
- Similac NeoSure
- Similac Alimentum
- Similac Alimentum Expert Care
- Similac Human Milk Fortifier Concentrated Liquid
- Similac Human Milk Fortifier Powder
- Similac Liquid Protein Fortifier
- Similac Special Care 20
- Similac Special Care 24
- Similac Special Care 24 High Protein
- Enfamil Human Milk Fortifier Acidified Liquid
- Enfamil Human Milk Fortifier Powder
- Similac Special Care 30
- Similac Human Milk Fortifier Hydrolyzed Protein- Concentrated Liquid
- Enfacare Powder
- Enfamil Human Milk Fortifier Liquid High Protein
- Enfamil Milk Fortifier Liquid Standard Protein
- Enfamil NeuroPro Enfacare
- Enfamil Premature 20 Cal
- Enfamil Premature 24 Cal
- Enfamil Premature 24 Cal/fl oz HP
- Enfamil Premature 30 Cal
- Enfamil 24 and DHA & ARA Supplement
According to the lawsuits filed against Abbott and Mead Johnson, these products have no warnings about the potential dangerous side effects. In addition, the companies marketed their products as safe for premature infants despite the potential risks.
At the current pace, it’s expected that the first bellwether trials will happen in 2024. Once these trials conclude, the remaining cases will likely finish much faster. It’s probable that once the bellwether cases finish, both sides will use the information learned to negotiate a settlement.
Toxic baby formula linked to necrotizing enterocolitis
There are numerous studies that link toxic baby formula to negative health conditions for infants, including most commonly necrotizing enterocolitis. Necrotizing enterocolitis (NEC) is a gastrointestinal problem that primarily impacts premature babies. With this condition, the infant’s intestinal tissue becomes inflamed, leading to the death of the tissue. In addition, holes may form within the intestine, where bacteria can leak into the abdomen or bloodstream. In some cases, NEC may be mild, but others can experience life-threatening conditions.
Different types of enteral nutrition products are linked to necrotizing enterocolitis
One study from 2017 aimed to explore the effects of different formulas and human milk on the development of NEC in preterm infants. According to the study, preterm infants are extremely vulnerable to several morbidities and mortality and an increased risk of developing NEC. Roughly 5-12% of very-low birth-weight infants develop NEC, while 25-50% of those cases are fatal.
The study found that human milk is the best source of nutrition for preterm infants and for infants at risk of NEC. The researchers also state that “A Cochrane systematic review that evaluated the effect of DHM or bovine milk–based formula on health outcomes for preterm infants also determined that formula significantly increases the risk of NEC.” The study concludes that there may be some biases in the research and that more research is needed to answer remaining questions, such as why a small percentage of infants still develop NEC despite being fed exclusively human milk.
The connection between donor milk and NEC in the NICU
Another study aimed to learn whether the introduction of donor milk to infants in a neonatal intensive care unit (NICU) made a difference in the suspected rates of NEC, growth, length of hospital stay and feeding intolerance. To do this, the researchers explored the medical records of neonates (an infant less than 4 weeks old) in the NICU that met certain criteria, such as the type of milk or formula they received and when they received it.
The researchers concluded that infants who receive formula are at an increased risk of developing NEC. At the same time, there appeared to be no difference in feeding intolerance and some neonates who received fortified PDHM (pasteurized donor human milk) appeared to have better growth rates. In addition, there were no differences in length of hospital stay. This suggests that PDHM is the preferred method for avoiding NEC while also not harming growth rates or the length of hospital stays.
An exclusively human milk-based diet is associated with a lower rate of necrotizing enterocolitis
Finally, a third study from 2019 aimed to evaluate the health benefits of a purely human milk-based diet in extremely premature infants against that of a diet consisting of both human milk and bovine milk-based products. They did this by randomly separating premature infants into three groups, then assigned one group to receive bovine milk-based formula, while the other two groups received different amounts of pasteurized donor human milk.
In the end, the researchers concluded that for extremely premature infants, a human milk-based diet resulted in significantly lower rates of NEC compared to that of a diet based on a mother’s milk that was supplemented with bovine milk-based products.
Projected toxic baby formula lawsuit settlement amounts
As of this writing, there have yet to be any settlements in toxic baby formula-related lawsuits. This makes it hard to determine what a projected settlement may look like. However, it’s possible to make estimates based on previous lawsuits involving necrotizing enterocolitis. For example, some previous cases had compensation worth millions of dollars. Examples of this include:
- In 2019, parents of a two-day-old newborn in New York filed a lawsuit after the infant suffered from bowel loops distension, which is a common necrotizing enterocolitis symptom. In the lawsuit, the parents allege that the hospital failed to exclusively feed the infant breast milk and instead used a combination of breast milk and formula. In the end, the parents received a $1.34 million settlement.
- In 2018, a premature infant showed signs of necrotizing enterocolitis, with symptoms like anemia and respiratory distress. The child died shortly after, prompting the parents to file a malpractice lawsuit. The result was a settlement for $2.9 million.
Other related settlements include a $10 million dollar settlement in California, a $900,000 settlement in Florida and a $347,000 settlement in Louisiana. There have also been cases that went to trial, with one trial reaching a $5 million verdict in New York, and another $7 million verdict in Massachusetts.
There are many factors that can influence compensation amounts, including the severity of the complications that may be caused by toxic baby formula and whether the case goes to trial or the two parties reach a settlement. In addition, many prior cases were cases that featured doctors and nurses as defendants, rather than the formula manufacturers, which may impact verdict amounts. A baby formula lawyer can provide you with more information about what to expect in terms of potential settlement amounts.
Do you qualify for a toxic baby formula lawsuit?
According to recent lawsuits, Similac and Enfamil failed to warn consumers about the risks of necrotizing enterocolitis. If you had a premature infant who developed NEC after receiving toxic baby formula, you may be eligible for a lawsuit to receive compensation. To learn more, you should consult with a baby formula lawyer. They can help you determine whether your baby received toxic baby formula while they stayed at the hospital. In addition to helping you gather evidence for your case, a baby formula lawyer can walk you through the litigation process, including filing the correct paperwork, and can potentially help you reach a settlement.